GeneDx Holdings WGS GeneDx — Total Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by GeneDx Holdings in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about GeneDx Holdings's genedx — total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GeneDx Holdings's genedx — total revenue?
- GeneDx Holdings (WGS) reported genedx — total revenue of $101.5M in Q1 2026.
- How has GeneDx Holdings's genedx — total revenue changed year-over-year?
- GeneDx Holdings's genedx — total revenue increased by 16.5% year-over-year, from $87.12M to $101.5M.
- What is the long-term trend for GeneDx Holdings's genedx — total revenue?
- Over 2 years (2023 to 2025), GeneDx Holdings's genedx — total revenue has grown at a 47.5% compound annual growth rate (CAGR), from $194.38M to $423.09M.
- What does genedx — total revenue mean?
- Represents the total gross income generated by the GeneDx business segment from its primary diagnostic and genomic testing operations. This figure reflects the top-line performance before the deduction of any operating costs or expenses.